Match!
Giuseppe Tarantini
University of Padua
491Publications
40H-index
5,701Citations
Publications 491
Newest
Published on May 1, 2019in International Journal of Cardiology3.47
Alaide Chieffo58
Estimated H-index: 58
,
Francesco Burzotta46
Estimated H-index: 46
(UCSC: Catholic University of the Sacred Heart)
+ 16 AuthorsBelén Cid-Álvarez8
Estimated H-index: 8
Abstract Percutaneous coronary intervention (PCI) is establishing as the last remaining revascularization option in an increasing number of patients affected by complex coronary artery disease not suitable for surgery. Over the past decade, percutaneous left ventricular assist device (pLVAD) has increasingly replaced intra-aortic balloon pump to provide hemodynamic support during such non-emergent complex high-risk indicated procedures (CHIP) averting the risk of circulatory collapse and of adve...
Published on May 1, 2019in International Journal of Cardiology3.47
Marco De Carlo32
Estimated H-index: 32
,
Luca Testa35
Estimated H-index: 35
+ 13 AuthorsCiro Indolfi43
Estimated H-index: 43
Abstract Background Large prospective studies on the use of bioresorbable vascular scaffolds (BVS) for diffuse coronary artery disease are lacking. IT DISAPPEARS is a large multicentre prospective registry investigating the short and long-term outcomes of everolimus-eluting BVS in patients with long coronary lesions and/or multivessel coronary artery disease (ClinicalTrials.gov: NCT02004730). We hereby report the 2-year outcomes of the registry. Methods We enrolled 1002 patients with complex les...
Published on May 1, 2019in International Journal of Cardiology3.47
Andreas Schäfer39
Estimated H-index: 39
,
Andreas Schäfer36
Estimated H-index: 36
(MHH: Hannover Medical School)
+ 13 AuthorsJiri Maly7
Estimated H-index: 7
Abstract For patients with myocardial infarct-related cardiogenic shock (CS), urgent percutaneous coronary intervention is the recommended treatment strategy to limit cardiac and systemic ischemia. However, a specific therapeutic intervention is often missing in non-ischemic CS cases. Though drug treatment with inotropes and/or vasopressors may be required to stabilize the patient initially, their ongoing use is associated with excess mortality. Coronary intervention in unstable patients often l...
12345678910